Healthcare -
Biotechnology - NASDAQ - US
$ 2.08
8.9 %
$ 75.1 M
Market Cap
-0.47
P/E
INO - COST OF REVENUE
Cost of Revenue INO - Inovio Pharmaceuticals, Inc.
3.5 M
LAST VALUE
-13.94%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR